OMNIlife Science announces the release of the APEX K1 Hip System

Friday, 25 August 2006 00:00

OMNI life science, Inc., a medical device company based in Raynham Massachusetts and focused on the design, manufacture and distribution of Orthopaedic Joint Replacement Products, announced today that it had received FDA 510k approval for its APEX K1 Hip Stem. This new monoblock hip stem enhances OMNIlife Science’s already strong Modular Hip Stem product offering. Dave LaSalle, OMNIlife Science acting CEO said “with the addition of the K1 hip stem OMNI can now offer a one piece dual taper design hip stem in addition to our existing K2 Modular dual taper type stem. The resulting K to those customers who prefer this type of product. The K1’s unique design integrates with our current K2 modular hip stem permitting intraoperative selection of either a one piece will be used to enhance and expand OMNI’s Apex Modular Acetabular Cup system product offering. George Cipolletti, President and CEO of OMNIlife Science said “with the approval of ApeX-LNK we are now able to offer highly cross linked polyethylene to our customers who previously could only obtain this type of technology from our much larger competitors.”